Yes, but WPATH is increasingly out of favor. You're the one who is out of date here. If everyone was following WPATH recommendations precisely, the bulk of my comments about what we don't know would be clinically irrelevant. With WPATH viewed as too restrictive, however, it's less clear when understanding to what degree transness is a spectrum (among other things) will be clinically relevant.

Regarding health risks--I could well be the one out of date; I haven't checked up on the latest research there. It didn't seem, when I looked into it a few years ago, that it could be settled in less than decades due to sample size issues and insufficient baseline limiting how well we could measure risk, but if they've found and fixed the problem, that's great!

Anyway, my primary point was only supposed to be that you had overstated what is known about the neurological basis of trans identity. I'm not entirely sure how we ended up on the topic of the appropriateness of gender affirming care.